Skip to main content
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (IST:GENIL)
Turkey flag Turkey · Delayed Price · Currency is TRY
8.55
+0.01 (0.12%)
Last updated: Mar 9, 2026, 3:26 PM GMT+3

IST:GENIL Revenue

In the year 2025, Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi had annual revenue of 19.18B TRY with 30.13% growth. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi had revenue of 4.82B in the quarter ending December 31, 2025, with 0.46% growth.

Revenue
19.18B
Revenue Growth
-0.59%
P/S Ratio
2.00
Revenue / Employee
28.54M
Employees
672
Market Cap
38.43B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202519.18B4.44B30.13%
Dec 31, 202414.74B2.97B25.25%
Dec 31, 202311.77B1.13B10.62%
Dec 31, 202210.64B8.14B325.34%
Dec 31, 20212.50B351.38M16.34%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MLP Saglik Hizmetleri A.S. 42.16B
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. 7.24B
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. 172.01B
Deva Holding A.S. 19.25B
Tapdi Oksijen Özel Saglik ve Egitim Hizmetleri Sanayi Ticaret A.S. 2.60B
Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi 1.35B
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi 709.08M
Fonet Bilgi Teknolojileri A.S. 526.48M
Revenue Rankings